PRIMARY STUDY

Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis

Key Findings:  Myrtenal and β-caryophyllene oxide, used in a petroleum ether extract of Liquidambaris Fructus in this experiment, showed the potential to suppress NLRP3 inflammasome activation, potentially leading to therapeutic uses in the treatment of inflammatory symptoms related to conditions like rheumatoid arthritis.

Type of Study:  Animal Study

Study Sample Size:  36

Study Result:  Positive

Study Location(s):  China

Year of Pub:  2021


Cannabinoids Studied:  Other Related Compounds

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  ß-Caryophyllene

Ligands Studied:  Pro-inflammatory cytokines

Route of Administration:  Oral (Ingestion)



Link to study